雄烯二酮
Search documents
赛托生物：暂无直接生产适用于COPD的制剂
Zheng Quan Ri Bao Wang· 2025-08-20 12:12
Group 1 - The company, Saito Bio (300583), produces key starting materials for common COPD treatments, including dehydroepiandrosterone, betamethasone, and indacaterol maleate [1] - The company does not currently produce formulations specifically for COPD [1]
赛托生物(300583.SZ)：暂无直接生产适用于COPD的制剂
Ge Long Hui· 2025-08-20 07:08
Group 1 - The company produces key starting materials for common COPD (Chronic Obstructive Pulmonary Disease) treatments, including dehydroepiandrosterone, betamethasone, and indacaterol maleate [1] - The company does not currently produce formulations specifically for COPD [1]